BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35394612)

  • 1. Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options.
    Zeng R; Glaubitz S; Schmidt J
    Neurotherapeutics; 2022 Apr; 19(3):911-921. PubMed ID: 35394612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Classification and Management of Inflammatory Myopathies.
    Schmidt J
    J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies.
    Khadilkar SV; Dhamne MC
    Ann Indian Acad Neurol; 2020; 23(4):458-467. PubMed ID: 33223661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic inflammatory myopathies.
    Lundberg IE; Fujimoto M; Vencovsky J; Aggarwal R; Holmqvist M; Christopher-Stine L; Mammen AL; Miller FW
    Nat Rev Dis Primers; 2021 Dec; 7(1):86. PubMed ID: 34857798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic therapy in the idiopathic inflammatory myopathies.
    Khoo T; Limaye V
    Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune inflammatory myopathies.
    Dalakas MC
    Handb Clin Neurol; 2023; 195():425-460. PubMed ID: 37562881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myopathies.
    Amato AA; Greenberg SA
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
    Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the treatment of myositis.
    Glaubitz S; Zeng R; Schmidt J
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X19886494. PubMed ID: 31949477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC
    Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic inflammatory myopathies: a review.
    Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
    Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies: Pathogenic or epiphenomenon.
    Galindo-Feria AS; Wang G; Lundberg IE
    Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101767. PubMed ID: 35810122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33916864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.